Andrea S Henden

11PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyHaematological tumoursRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 30, 2026
Preventing infections after CD19-directed chimeric antigen receptor T-cell therapies for lymphoma: a consensus practice statement.

|Sep 10, 2026
ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand.

|Mar 27, 2026
Prospective Biomarkers of SARS-CoV-2 Vaccine Seroconversion in Patients with Haematological Malignancies.

Sophie C Hamann, Katie E Lineburg, Louise Ng

|Feb 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Feb 12, 2026
Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An international survey of current practice.

Aleece MacPhail, Justin Loke, Brett L Houston

|Jun 11, 2025
Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ disease.

Andrea S Henden, Katie E Lineburg, Archana Panikkar

Pageof 2

Frequent Collaborators

3 joint publications

Siok-Keen Tey

3 joint publications

Ashleigh P Scott

2 joint publications

Philip Wong

2 joint publications

Jason P Butler